JPM

305.36

+0.03%↑

BAC

52.58

-0.45%↓

WFC

86.03

-0.92%↓

163.85

-0.76%↓

AXP

357.96

-0.99%↓

JPM

305.36

+0.03%↑

BAC

52.58

-0.45%↓

WFC

86.03

-0.92%↓

163.85

-0.76%↓

AXP

357.96

-0.99%↓

JPM

305.36

+0.03%↑

BAC

52.58

-0.45%↓

WFC

86.03

-0.92%↓

163.85

-0.76%↓

AXP

357.96

-0.99%↓

JPM

305.36

+0.03%↑

BAC

52.58

-0.45%↓

WFC

86.03

-0.92%↓

163.85

-0.76%↓

AXP

357.96

-0.99%↓

JPM

305.36

+0.03%↑

BAC

52.58

-0.45%↓

WFC

86.03

-0.92%↓

163.85

-0.76%↓

AXP

357.96

-0.99%↓

Начало・Списък с акции・Walker & Dunlop Inc

Walker & Dunlop Inc

Отворен

СекторФинансови

79.13 -4.64

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

79.5

Максимум

82.98

Ключови измерители
By Trading Economics
Приходи	30M 33M
Продажби	59M 296M
P/E Средно за сектора	26.346 27.54
Дивидентна доходност	3.08
Марж на печалбата	11.191
Служители	1,399
EBITDA	43M 122M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+12.46% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	3.08% 3.88%
Следващи печалби	6.11.2025 г.
Следваща дата на дивидент	5.12.2025 г.
Следваща дата на екс-дивидент	21.11.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	337M 2.9B
Предишно отваряне	83.77
Предишно затваряне	79.13

Настроения в новините

By Acuity

50%

190 / 529 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

70.995 / 76.69 Подкрепа & съпротива

Walker & Dunlop Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

28.10.2025 г., 23:50 ч. UTC

Горещи акции

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28.10.2025 г., 23:25 ч. UTC

Печалби

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28.10.2025 г., 23:18 ч. UTC

Печалби

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28.10.2025 г., 22:20 ч. UTC

Печалби

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28.10.2025 г., 22:13 ч. UTC

Печалби

Wal-Mart de Mexico Net Profit Falls in 3Q

28.10.2025 г., 21:38 ч. UTC

Печалби

Correction to Visa Sales Jump Article

28.10.2025 г., 21:17 ч. UTC

Печалби

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28.10.2025 г., 21:07 ч. UTC

Печалби

Visa Sales Jump as Consumers Keep Spending -- Update

28.10.2025 г., 21:02 ч. UTC

Печалби

Mondelez Tempers Outlook as Costs Rise

28.10.2025 г., 23:51 ч. UTC

Пазарно говорене

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28.10.2025 г., 23:42 ч. UTC

Пазарно говорене

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28.10.2025 г., 23:02 ч. UTC

Печалби

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28.10.2025 г., 23:01 ч. UTC

Печалби

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28.10.2025 г., 22:46 ч. UTC

Печалби

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28.10.2025 г., 22:45 ч. UTC

Печалби

SK Hynix 3Q Net KRW12.6T >000660.SE

28.10.2025 г., 22:44 ч. UTC

Печалби

SK Hynix 3Q Rev KRW24.44T >000660.SE

28.10.2025 г., 22:43 ч. UTC

Печалби

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28.10.2025 г., 22:42 ч. UTC

Печалби

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28.10.2025 г., 22:40 ч. UTC

Печалби

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28.10.2025 г., 22:40 ч. UTC

Печалби

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28.10.2025 г., 22:22 ч. UTC

Печалби

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28.10.2025 г., 22:22 ч. UTC

Печалби

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28.10.2025 г., 22:22 ч. UTC

Печалби

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28.10.2025 г., 22:20 ч. UTC

Печалби

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28.10.2025 г., 22:02 ч. UTC

Печалби

Review & Preview: Earnings Extravaganza -- Barrons.com

28.10.2025 г., 21:42 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

28.10.2025 г., 21:42 ч. UTC

Пазарно говорене

Печалби

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28.10.2025 г., 21:20 ч. UTC

Печалби

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28.10.2025 г., 21:19 ч. UTC

Печалби

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28.10.2025 г., 21:18 ч. UTC

Печалби

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Сравнение с други в отрасъла

Ценова промяна

Walker & Dunlop Inc Прогноза

Ценова цел

By TipRanks

12.46% нагоре

12-месечна прогноза

Среден 96 USD 12.46%

Висок 97 USD

Нисък 95 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Walker & Dunlop Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Walker & Dunlop Inc през последните 3 месеца.

Техническа оценка

By Trading Central

70.995 / 76.69Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Настроение

By Acuity

190 / 529 Класиране в Финансови

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.